Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 6-(acetylamino)hexanoic Acid
2. 6-acetamidohexanoic Acid
3. 6-acetylaminocaproic Acid
4. 6-acetylaminocaproic Acid, Calcium Salt
5. 6-acetylaminocaproic Acid, Monosodium Salt
6. Acexamic Acid
7. Celuton
8. Cy168e
9. Epsilon-acetylaminocaproic Acid
10. N-acetylamino-6-hexanoic Acid
11. Nas-501
12. Plastenan
13. Sodium Acexamate
14. Zinc Acexamate
1. Zinc Acexamate
2. 70020-71-2
3. Zinc;6-acetamidohexanoate
4. 811d513q1n
5. Hexanoic Acid, 6-(acetylamino)-, Zinc Salt (2:1)
6. Copinal
7. Unii-811d513q1n
8. Copinal (tn)
9. Acexamate Zinc
10. Zinc 6-(acetylamino)hexanoate (2:1)
11. Schembl1643738
12. Acexamate Zinc [who-dd]
13. Dtxsid20220304
14. Zinc Acexamate [ep Monograph]
15. Zinc N-(acetylamino)-6-hexanoate
16. Db-082106
17. Ft-0687297
18. D07558
19. .epsilon.-acetamidocaproic Acid Zinc Salt
20. .epsilon.-acetamidocaproic Acid Zinc Salt [mi]
21. Q27269190
| Molecular Weight | 409.8 g/mol |
|---|---|
| Molecular Formula | C16H28N2O6Zn |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 10 |
| Exact Mass | 408.123878 g/mol |
| Monoisotopic Mass | 408.123878 g/mol |
| Topological Polar Surface Area | 139 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 151 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
ABOUT THIS PAGE
A Epsilon-Acetamidocaproic Acid Zinc Salt manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Epsilon-Acetamidocaproic Acid Zinc Salt, including repackagers and relabelers. The FDA regulates Epsilon-Acetamidocaproic Acid Zinc Salt manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Epsilon-Acetamidocaproic Acid Zinc Salt API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Epsilon-Acetamidocaproic Acid Zinc Salt manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Epsilon-Acetamidocaproic Acid Zinc Salt supplier is an individual or a company that provides Epsilon-Acetamidocaproic Acid Zinc Salt active pharmaceutical ingredient (API) or Epsilon-Acetamidocaproic Acid Zinc Salt finished formulations upon request. The Epsilon-Acetamidocaproic Acid Zinc Salt suppliers may include Epsilon-Acetamidocaproic Acid Zinc Salt API manufacturers, exporters, distributors and traders.
click here to find a list of Epsilon-Acetamidocaproic Acid Zinc Salt suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Epsilon-Acetamidocaproic Acid Zinc Salt Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Epsilon-Acetamidocaproic Acid Zinc Salt GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Epsilon-Acetamidocaproic Acid Zinc Salt GMP manufacturer or Epsilon-Acetamidocaproic Acid Zinc Salt GMP API supplier for your needs.
A Epsilon-Acetamidocaproic Acid Zinc Salt CoA (Certificate of Analysis) is a formal document that attests to Epsilon-Acetamidocaproic Acid Zinc Salt's compliance with Epsilon-Acetamidocaproic Acid Zinc Salt specifications and serves as a tool for batch-level quality control.
Epsilon-Acetamidocaproic Acid Zinc Salt CoA mostly includes findings from lab analyses of a specific batch. For each Epsilon-Acetamidocaproic Acid Zinc Salt CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Epsilon-Acetamidocaproic Acid Zinc Salt may be tested according to a variety of international standards, such as European Pharmacopoeia (Epsilon-Acetamidocaproic Acid Zinc Salt EP), Epsilon-Acetamidocaproic Acid Zinc Salt JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Epsilon-Acetamidocaproic Acid Zinc Salt USP).
LOOKING FOR A SUPPLIER?
